Samsung Partners with Alcedis to Validate Galaxy Watch Health Data for Clinical Trials
By
Kezia Jungco
Summary
Samsung has partnered with German clinical research organization Alcedis to explore using Galaxy Watch biometric data in clinical trials for pharmaceutical research. The collaboration aims to validate whether real-world wearable health signals can serve as digital endpoints or biomarkers for evaluating drug safety, efficacy, and patient outcomes. The article discusses the implications for healthcare IT and the broader shift of consumer wearables into regulated clinical research settings.
Source
bskySamsung Partners with Alcedis to Validate Galaxy Watch Health Data for Clinical Trialstechrepublic.comKey quotes
· 3 pulledOn June 24, Samsung Electronics announced a partnership with German digital clinical research organization Alcedis to explore whether Galaxy Watch biometrics can support clinical trials for pharmaceutical and research organizations.
The companies plan to study how real-world signals from consumer wearables could become validated endpoints or biomarkers for evaluating drug safety, efficacy, and patient outcomes.
For healthcare IT teams, the bigger question is not whether smartwatches can collect more data. It is whether tha
You might also wanna read
Foundation Models for Wearable Behavioral Data Improve Health Predictions
Researchers developed foundation models for behavioral data from wearable devices using over 2.5 billion hours of data from 162,000 individu
arxiv.org·10mo ago
Engineering Analysis of Health Wearables: How Medical Devices Balance Precision and Consumer Design
The article explores the engineering and design behind modern health wearables like Oura Ring, Dexcom G7, Omnipod, and Jabra Hearing Aids, u
lumafield.com·4mo agoGalaxy Watch Blood Pressure Trends: Why Samsung Dropped Vascular Load
Understanding the Context Behind Wearable Sensor Data
The article discusses the potential of wearable devices like smartwatches and fitness trackers to capture extensive health data but highligh
research.google·11mo ago
Samsung discontinues Vascular Load feature on Galaxy Watches in US, but here’s the alternative
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
sfconservancy.org·6mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.